Adamis Pharmaceuticals reported 13.58M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamis Pharmaceuticals ADMP:US 13.58M 2.36M
Adma Biologics ADMA:US $ 31.57M 1.19M
Brainstorm Cell Therapeutics BCLI:US $ 7.37M 1.06M
Cara Therapeutics CARA:US $ 18.3M 680K
Cerulean Pharma CERU:US $ 16.4M 0.34M
GlaxoSmithKline GSK:LN 24278M 608M
Glaxosmithkline GSK:US $ 24278M 608M
Merk MRK:US $ 22316M 1556M
Pfizer PFE:US $ 39268M 3403M